G-CSF Fails to Benefit Acute Ischemic Stroke Patients

I wrote about this in Feb. 2012, why was a new trial needed?

Neutropenia Drug Falls Flat for Acute Stroke

http://www.tctmd.com/show.aspx?id=119920 

Key Points:

• At 90 days, mortality similar with vs. without G-CSF in acute ischemic stroke patients
• Modified Rankin score, NIHSS score, infarct volume also similar between groups
• Study fails to translate preclinical promise to clinical benefit, authors say

 Table at link.